Tag: drugs

Port strike could cause severe healthcare supply shortages, AORN warns

Editor's Note A joint communication from AORN and the Association of Healthcare Value Analysis Professionals (AHVAP, a strategic partner of AORN) provides advice and resources for affiliated healthcare professionals who could be impacted by the recent strike by port workers across major US shipping ports. Issued September 30, the statement…

Read More

By: Matt Danford
October 1, 2024
Share

Statistical models aim to improve surgical patient pain management

Editor's Note Researchers at MIT and Massachusetts General Hospital (MGH) have developed statistical models to improve how anesthesiologists manage unconscious pain, or nociception, during surgery, according to a September 23 report in News Medical. Derived from over 18,000 minutes of surgery data across 101 abdominal procedures, the models aim to…

Read More

By: Matt Danford
September 25, 2024
Share

California updates guidance on CRNA scope of practice

Editor's Note Confusion about the scope of practice for Certified Registered Nurse Anesthetists (CRNAs) prompted The California Department of Public Health to update guidelines for acute care hospitals, MedPage Today reported September 18. Issued after violations at two Modesto hospitals resulted in hundreds of cancelled surgeries, a letter from the…

Read More

By: Matt Danford
September 20, 2024
Share

Study: Preventing antibiotic-resistant infection surge could save millions

Editor's Note Research shows antibiotic-resistant infections could lead to 8.2 million deaths annually by 2050, representing a 75% increase from current rates, according to a September 17 article in HealthDay. Published in the Lancet, the new study highlights the growing threat of growing threat of antimicrobial resistance (AMR), predicting that…

Read More

By: Matt Danford
September 19, 2024
Share

Study: Adjuvant nivolumab reduces risk of death, lung cancer recurrence

Editor's Note An analysis of two phase-III trials showed adjuvant administration of nivolumab (Opdivo) plus chemotherapy reduces the risk of recurrence or death in patients with resectable non-small cell lung cancer (NSCLC) by 40% compared to neoadjuvant nivolumab plus chemotherapy alone, Medpage Today reported September 9. "With the caveat that…

Read More

By: Matt Danford
September 18, 2024
Share

Study: Postoperative potassium risk overstated for cardiac bypass patients

Editor's Note The common practice of administering potassium after bypass surgery can be safely abandoned in patients with normal blood levels, according to results of the randomized TIGHT-K trial. According to a September 3 report in Medscape, potassium supplementation is a widely accepted means of reducing the risk of postoperative…

Read More

By: Matt Danford
September 10, 2024
Share

Study: Nearly 10% of patients on prescription opioids develop dependency or disorder

Editor's Note Research reveals nearly 10% of patients treated with prescription opioid painkillers develop opioid dependency or opioid use disorder (OUD), Healio reported on August 13. Additionally, nearly 30% of patients exhibit signs and symptoms indicating potential OUD. Originally published in the journal Addiction, the data are from a systematic…

Read More

By: Matt Danford
August 30, 2024
Share

How GLP-1 drugs impact health systems expansion, investment plans

Editor's Note A shuttered bariatric surgery center in Oklahoma last month is just one example of how the rise of Glucagon-like peptide-1 (GLP-1) agonists are reshaping health systems’ investments, Axios reported August 13. Rather than “massive hospital towers with cardiology clinics, dialysis beds and joint replacement centers,” the focus is…

Read More

By: Matt Danford
August 23, 2024
Share

Immunotherapy’s FDA approval expected to improve lung cancer treatment

Editor's Note The US Food & Drug Administration (FDA) has approved immunotherapy durvalumab for perioperative treatment of resectable non-small cell lung cancer (NSCLC), according to an August 15 announcement. The approval is for durvalumab (Imfinzi, AstraZeneca) in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by durvalumab alone as…

Read More

By: Matt Danford
August 22, 2024
Share

Propofol study shows how consciousness research could improve anesthesia safety

Editor's Note Propofol research published in the journal Neuron has broader implications for enabling more precise, safer doses of anesthesia, according to an August 14 report in Anesthesiology News. According to the article, anesthesiologists tend to use higher doses of anesthetics because they rely on indirect measures, such as heart…

Read More

By: Matt Danford
August 16, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat